State Farm / Celsis In Vitro Inc. / SANDOZ INTERNATIONAL GMBH / Apple Inc. / Teva Pharm / AMGEN INC. / Antares Pharma / Amgen Manufacturing Limited / Council Inc. / 5 Defendant Sandoz Inc. / AstraZeneca LP / Fire & Casualty Co. / USA Inc. / PAUL / WEISS / RIFKIND / WHARTON & GARRISON LLP / SANDOZ INC. / Plaintiffs Amgen Inc. / Apotex Inc. / Medac Pharma Inc. / Athena Cosmetics Inc. / SANDOZ GMBH / SIDLEY AUSTIN LLP / Pfizer Inc. / Sanofi-Synthelabo / CellzDirect Inc. / Cases 4 Abbott Labs. / Allergan Inc. / Los Angeles Cellular Tel. Co. / Rohm & Haas Co. / Sonoran Inc. / Pozen Inc. / Eli Lilly & Co. / Page(s) 2 3 Kwikset Corp. / /
Country
United States / /
Currency
Rs / / /
Event
FDA Phase / Company Expansion / Legal Issues / /
Facility
GARRISON LLP Nicholas Groombridge / /
IndustryTerm
biosimilar filgrastim product / filgrastim product / treatment for colorectal cancer / reference product / biologic product / biological product / manufacturing patents / manufacturing information / treatment of melanoma / biosimilar product / biologic products / manufacturing / /
NaturalFeature
Beverly Hills / /
Organization
U.S. Patent and Trademark Office / Tahoe Reg’l Planning Agency / Medicare / Congress / University of Chicago / US Federal Reserve / FDA / Superior Court / /
Person
Life Ins / Van De Kamp / Dawson Chem / Tomas Philipson / Jennifer H. Wu / Alan Stone / Wendy A. Whiteford / Michael T. Wu / Vernon M. Winters / Lois M. Kwasigroch / Jennifer Gordon Peter Sandel / / /
Position
economist / General / ALL PARTIES AND THEIR COUNSEL / /
Case3:14-cvRS Document56 Filed02Page1 of